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a b s t r a c t
Regular consumption of moderate doses of wine is an integral part of the Mediterranean diet, which has
long been considered to provide remarkable health benefits. Wine's beneficial effect has been attributed
principally to its non-alcoholic portion, which has antioxidant properties, and contains a wide variety of
phenolics, generally called polyphenols. Wine phenolics may prevent or delay the progression of
intestinal diseases characterized by oxidative stress and inflammation, especially because they reach
higher concentrations in the gut than in other tissues. They act as both free radical scavengers and
modulators of specific inflammation-related genes involved in cellular redox signaling. In addition, the
importance of wine polyphenols has recently been stressed for their ability to act as prebiotics and
antimicrobial agents.
Wine components have been proposed as an alternative natural approach to prevent or treat
inflammatory bowel diseases. The difficulty remains to distinguish whether these positive properties are
due only to polyphenols in wine or also to the alcohol intake, since many studies have reported ethanol
to possess various beneficial effects. Our knowledge of the use of wine components in managing human
intestinal inflammatory diseases is still quite limited, and further clinical studies may afford more solid
evidence of their beneficial effects.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Introduction
A large number of studies, both in experimental models and in
humans, have investigated the antioxidant properties of wine. The
majority of studies on wine's effects have been performed on the
cardiovascular system; its moderate consumption is generally
considered to protect against coronary heart disease, and to be
associated with a lower incidence of oxidative stress-related
degenerative diseases [1]. However, during absorption wine com-
ponents accumulate in the intestinal mucosa, where they reach
higher concentrations than in other tissues, and can exert their
activities.
The gastrointestinal tract is the first barrier against environ-
mental agents, and is responsible for immune tolerance of micro-
biota [2]; it is prone to oxidative damage due to its exposure to the
luminal oxidants present in foods. For instance, discrete quantities
of reactive oxygen species (ROS) are essential for the recognition of
nutrients, commensal and pathogenic bacteria, as well as for killing
and processing pathogens during inflammatory immune response.
However, increased free radical production and impaired antiox-
idant defenses have been related to the progression of intestinal
chronic inflammation, which characterize a group of human dis-
eases known as Inflammatory Bowel Diseases (IBD) [3]. Mainte-
nance of the correct gastro-intestinal redox balance, which depends
on dietary compounds, is thus an important aspect for human
health.
The beneficial effect of wine has been mainly attributed to its
non-alcoholic portion having antioxidant properties, which con-
tains a large variety of phenolic compounds; these are mostly
present in red wine [4]. Likewise implicated are antioxidants, such
as ascorbic acid and sulfur dioxide, normally added during white-
wine processing [5].
This review will discuss experimental and clinical data suggest-
ing a link between wine consumption and intestinal function.
In particular, it will focus on the relevant potential protective
mechanisms that wine components may exercise on the cell signal
network, specifically induced during tissue damage characterized
by oxidative and inflammatory reactions.
Maintenance of redox intestinal homeostasis
The intestinal tract is continually attacked by luminal microbes
and by oxidized compounds from the diet, exposing it to recurrent
oxidative changes. Intestinal epithelial cells act as a selective
permeable barrier, which allows the absorption of nutrients,
electrolytes and water by transcellular and paracellular pathways,
also affording their intracellular compartmentalization and traf-
ficking towards the body. These cells are able to regulate the traffic
of antigens towards gut-associated lymphoid tissues, in order to
discriminate between innocuous and pathogenic antigens, acting
as a crossroad between tolerance and the immune response.
Evidence for the need of a proper dietary intake of antioxidants
to maintain low intracellular levels of oxidative species is mani-
fold. ROS and their oxidized products may be considered as part of
a network signaling system controlled by antioxidant defenses.
For instance, moderate quantities of ROS can act as biological
signal molecules, which are involved in different phases of the
inflammatory immune response and of autophagic processes
activated by luminal agents in intestinal cells. These events imply
the production of hydrogen peroxide (H2O2) and superoxide
anion (O2d) or nitric oxide (NO) at specific intracellular sites, i.e.
mitochondria, membrane nicotinamide adenine dinucleotide
phosphate reduced (NADPH) oxidase, endothelial inducible NO
synthase (iNOS) and myeloperoxidase in inflammatory cells [6].
H2O2 regulate redox sensitive transduction pathways, such as
phosphatidylinositol 3-kinase/AKT, mitogen-activated protein
kinase/extracellular signal regulated kinase kinase / extracellular
signal-regulated kinase (ERK) and c-jun N-terminal kinase, and
also regulate activation of the oxidative stress-responsive nuclear
transcription factor-κB (NF-κB), which is involved in inflammatory
reactions [7,8]. However, although cell inflammation and oxidative
reactions are considered to be a primary host defense, excessive
inflammatory reactions, with overproduction of O2d, H2O2, NO
and HOCl by activated leukocytes, can overwhelm the tissue's
antioxidant defenses and may contribute to functional impairment
of the enteric mucosa, leading to an aberrant response to luminal
agents. These events have been extensively considered in the
pathogenesis of IBD and have been associated to chronic abnormal
inflammatory and immune responses [3].
An antioxidant intestinal environment reflects the intestinal
mucosa's response aimed at preventing oxidative damage, and is
maintained by a complex dynamic recycling system in which
different molecules undergo well-established oxido-reductions.
The chief molecules involved are antioxidant enzymes, i.e. super-
oxide dismutase, catalase and glutathione peroxidases, as well as
non-enzymatic molecules some of which originate from the diet,
such as ascorbic acid, tocopherols and amino-thiols compounds
[9]. To a great extent, ascorbate, reduced glutathione (GSH),
cysteine (Cys) and sulfur dioxide are produced under conditions
used in winemaking (see section below).
Principal non-alcoholic components of wine
There is a wide variation in wine compounds, the composition
being affected by several factors including the grape varieties used,
winemaking technology, and conditions under which the wine is
aged and stored. The most abundant non-alcoholic components
are phenolic compounds, which are generally called polyphenols,
and that may roughly be divided as flavonoid and non-flavonoid
compounds. Wine flavonoids can in turn be subdivided into
flavan-3-ols, anthocyanins and flavonols. Catechin and epicatechin
are the most representative flavan-3-ols in monomeric form;
proanthocyanidins are oligomers, while condensed tannins are
polymers. Non-flavonoid wine components are benzoic and
hydroxycinnamic acids (caffeic, ferulic and p-coumaric acids) with
their tartaric esters (caftaric, fertaric and coutaric acids), and
stilbenes [10,11].
Although Vitis vinifera is the dominant grape used in wine
production, there are significant varietal differences within this
species [12]; the phenolic composition of wine also depends on
processing in the winery [13]. Red wine is a whole-berry extract
made by fermenting the juice in the presence of grape skin and
seeds (which contain most of the phenols), while white wine is a
juice product. Thus the total amount of phenols found in a typical
glass of red wine is in the order of 100–200mg, versus 25–50mg
in a glass of white wine [10].
In red wine, tannins contribute to the mouth feel of wines, but
they also form pigmented polymers in association with anthocya-
nins, to provide the stable pigments that give red wine its long-
term color stability. In white wine, the most important phenolic
compounds are hydroxycinnamic acids and, in minor quantities,
flavan-3-ol monomers [10].
Phenolic concentration and composition change significantly
during vinification when considerable amounts of phenolics are
degraded or oxidized [14]. Aging or fermenting in oak barrels
enables oxygenation to occur, and various different compounds
with organoleptic properties are released from the wood. Oak-
treated wines contain volatile phenols including vanillin, furanic
derivatives, lactones, terpenes and hydrolysable tannins (mainly
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gallotannins and ellagitannins), which affect the color, flavor and
texture of the wine [15,16].
An important common practice in winemaking, especially when
bottling white wines, is to add compounds that eliminate oxidative
spoilage, by efficient free-radical scavenging. Sulfated compounds are
the main antimicrobial and antioxidant additives of white wine; they
are present in the wine in different forms depending on their
solubility and pH, but mainly as sulfur dioxide, sulfates and sulfites.
These compounds are often used in combination with ascorbic acid,
which appears to be important for its ability to protect sulfur dioxide
and wine phenolic components against oxidation. However, ascorbic
acid should only be employed as a complement to sulfur dioxide,
because it can also exhibit pro-oxidant activity depending on its
concentration, and may be responsible for the browning of white
wine due to its reactionwith (þ)catechin, to form yellow xanthylium
cations pigments [17].
Quantitative and qualitative analyses of the amino-thiols present
in grapes and wine have been reported; compounds found include
GSH, N-acetylcysteine, Cys and omoCys, especially in white wines
[18]. These compounds play an important role in slowing down the
browning process due to natural oxidation. An important role in
wine quality has been attributed to GSH for its high antioxidant
activity and its influence on wine aroma [19]. Once grapes are
crushed, hydroxycinnamic acids are rapidly oxidized by polyphenol
oxidase enzymes, forming quinones, which in turn polymerize and
lead to the formation of brown polymerized pigments in the must.
GSH can avoid the formation of polymers, quickly reacting with
quinones, and producing glutathionil-adducts (called grape reaction
products—GRP). These compounds cannot be oxidized by polyphenol
oxidase: thus the browning potential of musts may depend on their
containing large amounts of GSH, and consequently having a high
GRP concentration [20].
GSH has been also detected in red wines, but in lower concentra-
tions than in white wines; the content varies widely depending on
the winemaking process and aging conditions [21]. It has recently
been proposed that glutathione could be used as an antioxidant
additive, to maintain the antioxidant efficacy of sulfur dioxide and
ascorbic acid high, thus avoiding the formation of xanthylium cations
[22]. Interestingly, changes in GSH levels during fermentation
depend on the yeast strain; this points to a direct relationship
between GSH metabolism and yeast metabolism [23]. Finally, the
addition of GSH to grape juice before fermentation has been found to
increase the hydrogen sulfide content [24].
However, rather than directly contributing to increasing exo-
genous intestinal antioxidant defenses, amino-thiols and ascorbic
acid in wine act to avoid oxidation of phenolic compounds that,
in turn, improve the activity and expression of endogenous GSH-
related enzymes [25,26]. The real players in terms of the antiox-
idant and anti-inflammatory activities attributed to wine are the
polyphenols, which can reach higher concentrations in the gut
than other known antioxidants contained in the diet.
Bioavailability of wine phenolics in the intestinal tract: the
importance of microbiota
Some classes of wine phenolics are quite resistant to gastric
digestion and reach the intestinal lumen as native compounds
[27]. Generally, polyphenols are ingested in the conjugated form;
once in the lumen phenols may directly cross the intestinal barrier
and be metabolized by the enterocytes, or may function as a
substrate for bacterial metabolism [28].
The interaction between gut microflora and wine phenolics is
important for the bioavailability of most of the latter, and appears
to be closely dependent on the bacterial population and intestinal
transit time. Feeding studies with specific phenolics consumed by
either healthy volunteers or ileostomy subjects underlined the
contribution of microbiota to the interindividual variability
observed in the metabolism of these compounds [29,30].
Proanthocyanidins and condensed tannins must be biotrans-
formed by colonic bacteria before absorption, in order to yield a
great variety of phenolic acids metabolites [31]. Hydrolysable tannins
undergo similar bacterial degradation, yielding urolithin A and B
metabolites that are absorbed in large amounts into the bloodstream,
and may be detected in human urine and feces [32–34].
The anthocyanin fraction, which is stable to gastric conditions
[35], may be partly absorbed from the stomach [36,37], but most of
it undergoes gut microflora metabolization, via glycosylation and
C-ring fission, leading to phenolic acids and aldehydes [38,39].
A good proportion of flavonols is absorbed in the intestinal
tract. Quercetin is predominantly present in wine as quercetin-β-
glycoside; it is absorbed in larger quantities in the rat intestine
when ethanol is present [40]. In addition, low levels of quercetin-
3-O-rhamnoglucoside (rutin) and quercetin-3-O-rhamnoside
(quercitrin) are also found in wine [41], and can be hydrolyzed
to quercetin only by α-rhamnosidases from colonic microflora in
the large intestine [42].
Bioavailability of flavan-3-ols is greatly influenced by the
degree of polymerization: catechin and epicatechin are readily
absorbed in the small intestine by both passive and carrier-
mediated diffusion [43]. However, their most abundant metabo-
lites also arise from intestinal microbial catabolism [44]. Among
the most common non-flavonoid compounds present in wine,
hydroxycinnamic acids are esterified to quinic acids to form
chlorogenic acids mainly by colonic commensal bacteria [42].
Some of the antioxidant, anti-inflammatory and anti-
carcinogenic effects induced by dietary wine phenolics and their
metabolites might also be attributed to their ability to modulate
intestinal microbiota populations, as prebiotics. Overall, the pre-
biotic activity of wine phenolics may derive from their ability to
interact with microbes' growth, both by inhibiting detrimental
bacteria and by stimulating beneficial bacteria in the gut, in
particular Lactobacteria and Bifidobacteria [45,46]; this influence
depends on the bacterial concentration/type, the strains, the
specific intestinal tract and interindividual variation [29]. Com-
bined analytical methods provided comprehensive information on
different microbial metabolites obtained from in vitro fermenta-
tion of fecal batches from 10 healthy volunteers with a mixture of
red wine and grape juice [47].
The effect on bacterial growth of different grape-seed extracts,
characterized by their content of monomeric flavanols, procyanidins
and gallates, was tested directly on various Lactobacteria and
Bifidobacteria species: growth inhibitory effects within species were
reported, inhibition being specifically dependent on increased pro-
cyanidin content [45]. in vivo studies on male broiler Cobb chicks fed
with grape-seed extract showed greater biodiversity in their gut
microbiota populations of Lactobacillus, increased Enterococcus than
those fed an ordinary diet, depending on the portion of intestinal
tract [48]. There is some evidence of a possible antimicrobial effect of
pure phenolics and of wine extracts, either from Argentinian wine
varieties against Escherichia coli [49] or from Serbian red wines
against different Gram-positive and Gram-negative strains [50].
Regarding the effect of ethanolic fraction of wine on intestinal
bacteria growth, acute alcohol abuse increases mucosal suscept-
ibility to microbial pathogens, probably by altering molecules
involved in pathogen recognition, for example Toll like receptor 4,
and consequently triggering inflammatory cell signals [51]. Con-
versely, low doses of alcohol have long been known to exercise
bactericidal activity, which is improved by the acid pH of wine; the
activity against the gastrointestinal pathogens Salmonella enterica
and E. coli was markedly increased in whole wine compared
to either dealcoholized wine or ethanol alone, suggesting that
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suggesting that other substances in non-alcoholic fraction of wine
might synergize the anti-bacterial effect of ethanol [52].
The antiviral properties of red wine have been studied in depth.
Among more than 100 red wine extracts, from the USA, Europe and
South America, Cabernet Sauvignon has been found to strongly
inhibit calcium transport through chloride channels on the apical
plasma membrane of intestinal epithelial cells, and consequently to
reduce diarrhea caused by rotavirus in neonatal mice [53].
Effects of wine on intestinal damage
Epidemiological studies have demonstrated that five to seven
servings of fresh fruit and vegetables and two glasses of wine per day
can lead to a prolonged healthy life [54]. A relationship between life
expectancy and wine consumption was found in a cohort study in
middle aged men drinkers from seven Italian villages [55].
Regular consumption of moderate doses of red or white wine is
an integral part of the Mediterranean diet, in which the maintenance
of a correct intake of oxidizable foodstuffs, such as ω-6 polyunsatu-
rated fatty acids or cholesterol, and antioxidants is considered the
key mechanism of protection against the occurrence of coronary
events [56]. Increasing interest has been shown in the effect of
wine compounds, especially polyphenols, to protect against human
inflammatory and degenerative diseases other than cardiovascular. In
fact, even if polyphenols are present in tissues in quite low
concentrations, they can target signaling cascades involved in differ-
ent cellular functions, thus exerting many health benefits [29]. As a
consequence, assuming that these compounds reach very high levels
in the intestine, their maximal effects in this organ might be
hypothesized. However, of the many studies concerning wine's
beneficial effects on human intestinal diseases, most are either
in vitro studies in which phenolic components were added singly
to cells, or experimental animal models of colitis (Fig. 1).
in vitro evidence
ROS and their oxidized products may be considered as part of a
network signaling system controlled by antioxidant defenses in the
gut. The protective effect of wine polyphenols is chiefly due to their
antioxidant properties, acting directly as free-radical scavengers, or
indirectly, by interfering with specific inflammatory molecules
involved in cellular redox signaling pathways. These molecules include
COX-2, iNOS, ILs, transcription factors, i.e. nuclear factor erythroid-2-
related factor 2 (Nrf2), NF-κB and activator protein 1 [57,58].
Among different polyphenols, resveratrol is widely recognized as
the best wine component for its ability to inhibit cancer progression
by modulating in vitro cell signals activated by oxidative changes
[59]. Its antiproliferative activity has been tested in different intest-
inal cancer cells [60]. In CaCo-2 and SW480 human colon cancer cells
resveratrol has been shown to inhibit lipopolysaccharide (LPS)-
induced NF-κB activation [61], to induce cell–cycle arrest and
apoptosis, and to decrease collagen synthesis in primary rat intestinal
smooth muscle cells isolated from colon muscularis externa [62].
Tannin procyanidin B2 has also been shown to protect CaCo-2
cells against oxidative stress, by regulating cascade signals invol-
ving ERK and p38 MAPK activation, translocation of Nrf2 and
consequent expression of glutathione S-transferase P1 [63].
With regard to experimental data on the modulation of intestinal
cell signaling by whole-wine components, chronic treatment of
CaCo-2 cells with a grape seed extract, at concentration similar to
that due to drinking 250mL of red wine per meal in a human subject
(containing approximately 67.4% procyanidins and 13.5% catechins
and procyanidin dimers) induced morphological and functional cell
changes leading to a differentiated phenotype [64].
A Portuguese red-wine extract enriched in anthocyanins has
been found to possess anti-inflammatory capacity in HT-29 colon
epithelial cells stimulated with a mix of TNF-α, IFN-γ and IL-1.
Wine extract decreased the degradation of Inhibitor of NF-κB, the
synthesis of inducible nitric oxide synthase, COX-2 and IL-8 [65].
Similarly, human colon-derived CCD-18Co myofibroblast cells pre-
treated with Port Barrel Reserve red wine polyphenolic extract
(LeNoir grapes—Texas) and then treated with LPS showed
decreased mRNA of both NF-kB and adhesion molecules, depend-
ing on the wine-extract concentration. Interestingly, this wine
extract induced miR-126, a microRNA that is involved in negative
regulation of vascular cell adhesion molecule-1 expression [66].
CaCo-2 cells treated with TNF-α confirmed the anti-inflammatory
effect of grape seeds and of grape marc meal-based feed additives
used for livestock nutrition, in that they inhibited NF-κB transac-
tivation and IL-1β, IL-8, monocyte chemotactic protein-1, chemo-
kine CXC ligand 1 expression [67].
Extracts of Sardinian wines (Cannonau and Vermentino) were
shown to possess strong antioxidant properties against pro-
oxidant tert-butyl hydroperoxide [41] and anti-inflammatory
activity in differentiated enterocyte-like CaCo-2 cells in presence
of a mixture of dietary oxysterols (cholesterol oxidation products),
which are able to induce inflammation by up-regulating intestinal
NADPH oxidase 1 and enhancing ROS production [68]. Notably,
Cannonau extract exerted a more efficient protective effect on the
oxysterol-dependent production of IL-6 and IL-8 than Vermentino
Fig. 1. Distribution of articles onwine effects on different diseases according to PubMed citations during the last 10 years. Left panel: number of articles published from 2004
to 2013 with the exclusion of reviews; word “wine”, together with the words “cardiovascular”, or “cancer”, or “diabetes”, or “Alzheimer disease” (AD) or “intestinal”, have
been considered as the keywords. Right panel: percentage of articles focused on words “wine” and “intestinal”, which included studies on animals, cell lines, or human trials.
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white wine extract [68]. This difference was ascribed to the phenolic
fraction, which is more abundant in red wine than in white wine.
In this connection, ex vitro studies showed that red wine possesses
great antioxidant capability on cholesterol oxidation [69].
Interestingly, 9 years ago Cabernet Shiraz red-wine extract
(South Australia) was found to reduce the secretion by differen-
tiated CaCo-2 cells of apolipoprotein B48, the marker of intestinal
chylomicrons. This inhibition might limit the availability of total
and free cholesterol content, thus reducing pro-atherogenic events
[70]. However, a recent study showed that red wine added to
apical compartment of these cytotypes in concentrations consid-
ered similar to dietary intake, inhibited LPS-dependent IL-6
induction, without altering high density lipoprotein-cholesterol
functionality [71].
Particular attention should be paid on intestinal barrier affected
by ethanolic matrix of wine. Acute low concentrations of ethanol
have been shown to disrupt confluent epithelial Caco-2 cells by
inducing apoptosis [72]. Conversely, chronic treatment of Caco-2 cells
with 1% ethanol stimulated cell differentiation and morphological
changes, i.e. microvillus density and elongation [64]. Studies on the
effect of wine on thiamine and folate absorption, the deficiency of
which has long been known to be involved in chronic alcoholism,
showed that both red and white wines inhibited apical uptake of
folate by Caco-2 cells; the same was true of alcohol-free wines.
Ethanol alone had a weak effect on reducing vitamin absorption;
at least some of this effect was concentration-dependent [73].
Further, studies by Pal and coworkers showed that both dealcoho-
lized and alcoholized red wines had similar effects on apoB48
secretion in intestinal CaCo-2 cells [70], thus supporting the impor-
tance of wine components other than ethanol in modulating
intestinal function.
Evidence in animals
As in the case of cellular studies, resveratrol in wine has been
proposed to induce suppression of colon-cancer incidence asso-
ciated with colitis in animals. Fischer F344 rats, in which experi-
mental colitis was induced with dextran sodium sulfate (DSS), fed
low doses of resveratrol similar to those hypothetically contained
in the daily diet of a person weighing 70 kg, have shown reduced
mucosal levels of inflammatory markers, such as prostaglandin E
(PGE)-2, COX-2 and PGE synthase-1, and improved colonic mucosa
architecture, with the specific induction of Bifidobacterium and
Lactobacillus, and reduction of E. coli growth [74]. Colitic C57BL/6
mice treated with resveratrol also showed a decrease in the
neutrophil percentage and T lymphocytes number expressing
TNF-α and IFN-γ in the mesenteric lymph nodes and colonic
lamina propria, as well as silent mating type information
regulation-1 (SIRT-1) protein increase [75].
Interestingly, powdered grape-seed extract, produced from
wine and grape-juice industrial by-products, having high concen-
tration of procyanidins, was also able to reduce histological
severity score in DSS-induced colitis in rats [76].
Studies on weaning piglets fed red wine pomace added to a
standard diet have shown it to inhibit gut-associated lymphoid
tissue activity, suggesting an immune preventive effect of wine
phenolic compounds in these animals’ intestinal tract. These
findings are important in view of attempts to counteract intestinal
inflammation and diarrhea, as well as growth deficiency, which
often occur in piglets during the weaning phase [77].
Beneficial effects of red wine extract (Rubesco, Rosso di
Torgiano, Italy) were observed in male Sprague-Dawley rats fed
a zinc-deficient diet, which induces severe intestinal morphologi-
cal changes, oxidative damage and inflammation. The red-wine
extract improved these morphological alterations and increased
glutathione peroxidase, catalase and myeloperoxidase activities in
the different parts of the small intestine. Further, increased mRNA
levels of the anti-inflammatory IL-10 were detected in jejunum,
as well as decreased expressions of cytokine-induced neutrophil
chemoattractant and of TNFα [78]. Wine-complex polyphenols and
tannins have been found to induce a significant decrease in
oxidative DNA damage in colonocytes isolated from male Fisher
344 rats fed a high-fat diet, which mimics the typical diet of
humans at high risk of colon cancer [79].
Human studies: influence of alcoholic and non-alcoholic fractions
Based on experimental data on the reduction of symptoms in
animals with acute colitis, wine compounds have attracted major
scientific interest for their potential applications as food supple-
ments, in a physiological approach to treating IBD, with the possibi-
lity of altering the natural history of these chronic relapsing diseases.
In particular, phenolic compounds may be of interest in preventing
IBD and colitis-associated colorectal cancer development [58,80].
However, relatively few studies have concerned the effects of wine-
related phenolics on human intestinal diseases, and those reported
have yielded conflicting results. An important point on wine con-
sumption is associated to alcohol intake. The most important and
abundant alcohol in wine is ethanol, which is produced during grape
fermentation, and concurs to characterizing the properties of wine.
Scientific communities in different countries agreed that “mod-
erate” consumption of alcohol comprises about 15 g/day for
women and 30 g/day for men; this corresponds to 1–3 glasses
per day of wine containing 12–14% alcoholic fraction. The alcohol
content depends on the sugar concentration in the grapes and on
the yeast used; thus, the effects of different doses of ethanol on
intestinal functions must be investigated in adequate depth.
Numerous studies have aimed to establish the effect of a
moderate alcohol intake on human diseases. Unlike the effects
induced by high consumption of ethanol in beverages, low con-
centrations of alcohol appear to protect diabetic and atherosclero-
tic patients against cardiovascular diseases, especially lowering the
risk of ischemic coronary events. However, controversial results
from epidemiological studies suggest caution in making any
recommendations related to alcohol consumption [81].
Regarding the possible impact of ethanol on the gastrointest-
inal tract, the majority of studies have enrolled patients with
sustained alcohol consumption, which affects the motility of the
esophagus, stomach and small bowel, thus contributing to intest-
inal absorptive dysfunction. Alcohol's mechanism of action in
intestinal dysmotility appears mainly to be due to its influence
on brain–gut axis neurotransmission and on the muscular layers.
High concentrations of ethanol induce sustained oxidative and
inflammatory reactions. These events may contribute to motility
disorders, as well as causing serious mucosal injury, which is
considered high risk for colorectal cancer development [82,83].
However, short-term moderate social drinking in patients with
inactive IBD was evaluated in a prospective cohort study, including
Crohn's disease (CD) or Ulcerative Colitis (UC) subjects in clinical
remission, who drank red wine daily for 7 days (1–3 glasses of red
wine/day). This study showed that patients had delayed long-term
risk for disease relapse; the study authors suggested that moderate
red wine intake might be safe in inactive IBD. However, contra-
dictory effects on stool calprotectin and intestinal permeability
were found: a reduction in stool calprotectin was found in subjects
with UC, but there was a significant disruption of the epithelial
barrier in the small bowel of CD patients. The study authors
hypothesized that ethanol exerted different actions depending
on the type and intestinal location of the disease. Reduction in
stool calprotectin might be due to the effects of alcohol, inhibiting
the systemic immune system and neutrophils migration in UC;
conversely, alcohol might be deleterious in those intestinal areas
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that are already weak, and thus more susceptible to the negative
effects of alcohol. It remains difficult to distinguish whether
certain positive properties are actually due to alcohol itself, or to
other components in the wine [84].
Further, the role of exogenous sulfur dioxide present in wine in
the form of hydrogen sulfide as a potential player in the etiology of
intestinal disorders such as IBD and colorectal cancer has been
stressed: in this study, 81 patients with UC were recruited in order
to elucidate any association between individual dietary items and
disease activity. In this case, wine consumption was associated to the
presence of high doses of sulfites, which might be harmful for UC
[85]. Hydrogen sulfide has recently been hypothesized to induce pro-
inflammatory and genotoxic effects, for its interfering activity on
microbial growth and colonocyte metabolism in butyrate oxidation
[86]. A double-blind, placebo-controlled, randomized cross-over
study was performed in healthy volunteers underwent over a period
of 4 weeks a diet rich in polyphenols with grape juice or grape juice
combined with wine polyphenol extract. Metabonomic analyses
showed quantitative changes of microbiota, reflected as metabolic
outcome in feces only in subjects who consumed the mixture of
grape juice and wine extract with a reduction in isobutyrate, thus
suggesting the role of polyphenols in the modulation of the microbial
ecology of the gut [87].
In a crossover study with 20 patients with CD in remission, who
consumed randomly different alcoholic drinks with moderate etha-
nol content, included red and white wine, and pure ethanol, any
differences in alcohol absorption compared to healthy subjects were
found. However, abdominal pain manifestations were detected in CD
patients after consumption of Smirnoff Ice and Elephant beer with
high glucose concentration. This suggests that fermentation could be
responsible of intestinal bacteria overgrowth, thus playing a role in
abdominal pain and intestinal damage in IBD [88].
The great discrepancy among data concerning the action of the
alcohol contained in wine strengthens the notion that attention
should be paid in discriminating between the effects of alcohol
and those of other wine components.
Conclusions
In Western countries, consumers' demand for foods or food
supplements that help to prevent or manage diseases is continuously
increasing. Evidence strongly supports the hypothesis that moderate
wine consumption can prolong healthy life, and might also possess
preventive and/or therapeutic value in different human inflamma-
tory diseases. The beneficial activity of wine, especially that of red
wine, mainly arises from its high content of phenolic compounds
(graphical abstract); these can act directly, as free radical scavengers,
or indirectly, by interfering with specific inflammation-related genes
involved in cellular redox signaling pathways. With regard to
maintaining intestinal functions, wine phenolics reach much higher
concentrations in the intestinal mucosa than in other tissues; they
are thus strongly implicated in safeguarding the oxidative/antiox-
idant balance of the intestinal epithelial layer, concurring to increase
intracellular levels of antioxidants. In addition, most wine phenolics
primarily target the activity of the redox sensitive transcription factor
NF-κB, which controls the inflammatory cell signaling cascades that
have been implicated in the pathogenesis of IBD and colorectal
cancer development.
The importance of the changes in the colonic bacterial population
induced by wine phenolic compounds acting as prebiotics has
recently been stressed. The use of natural wine phenolics, by
restoring the microbial balance between detrimental and protective
luminal bacteria, might thus prevent inflammatory and oxidative
reactions, reducing mucosal injury in IBD. The influence on intestinal
diseases of the ethanolic wine fraction has also been investigated:
alcohol has long been known for its bactericidal effects, and has been
recently thought to positively modulate inflammatory and immune
responses, at least in low concentrations. However, most of wine's
antioxidant and anti-inflammatory capacity does not arise from its
alcohol content, but rather from its polyphenol content.
There is increasing pharmacological interest in identifying and
characterizing the natural compounds present in wine, which can
protect intestinal redox homeostasis and guard against inflamma-
tion. Several studies on intestinal cell lines or on experimental
animal models have shown that wine compounds are able to
reduce colonic injury.
However, knowledge on the beneficial effect of wine in human
intestinal diseases is not sufficient and is still limited because of
the small number of clinical trials. Furthermore, any such benefit
must be weighed against the unfavorable effects of the corre-
sponding consumption of ethanol.
Future perspectives thus require additional studies in humans
in order to reinforce the experimental evidence concerning the
beneficial effect of wine consumption on intestinal function, and
to correlate the right quantity of its specific compounds intake
with positive health outcomes.
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